Litcius/Paper detail

Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes

Renée Maria Saliby, Chris Labaki, Tejas Jammihal, Wanling Xie, Maxine Sun, Valisha Shah, Eddy Saad, M. Harry Kane, Soki Kashima, Katherine Sadak, Talal El Zarif, Deepak Poduval, Robert J. Motzer, Thomas Powles, Brian I. Rini, Laurence Albigès, Sumanta K. Pal, Bradley A. McGregor, Rana R. McKay, Sabina Signoretti, Eliezer M. Van Allen, Sachet A. Shukla, Toni K. Choueiri, David A. Braun

2024Cancer Cell42 citationsDOIOpen Access PDF

Topics & Concepts

Renal cell carcinomaJavelinImmunotherapyTargeted therapyKidney cancerCancer researchTranscriptomeMedicineNivolumabCarcinomaImmune checkpointOncologyImmune systemInternal medicineImmunologyBiologyCancerGeneGene expressionGeneticsThrowingMechanical engineeringEngineeringRenal cell carcinoma treatmentCancer Genomics and DiagnosticsRenal and related cancers
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes | Litcius